Top Markets
Coin of the day
Modalis Therapeutics Corporation Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

4883
Ранг среди акций #29674
Modalis Therapeutics Corporation focuses on discovering and developing... Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
Цена акции
$0.20877985
Рыночная капитализация
$20.11M
Изменение (1 день)
-3.03%
Изменение (1 год)
-66.13%
Страна
JP
Торговля Modalis Therapeutics Corporation (4883)

Категория

Коэффициент P/B для Modalis Therapeutics Corporation (4883)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Modalis Therapeutics Corporation, текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Modalis Therapeutics Corporation с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH
- -
KR